<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:department>Structural Biology</gtr:department><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/1A4928A2-632C-49AF-AA0F-66E902DFC05C"><gtr:id>1A4928A2-632C-49AF-AA0F-66E902DFC05C</gtr:id><gtr:name>Oswaldo Cruz Foundation (Fiocruz)</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C2399418-05BD-4570-AF1F-DAD12A990E0A"><gtr:id>C2399418-05BD-4570-AF1F-DAD12A990E0A</gtr:id><gtr:firstName>Jonathan</gtr:firstName><gtr:surname>Diprose</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/D9E45FE5-3B25-4E8F-84CD-063C1CE3F9D0"><gtr:id>D9E45FE5-3B25-4E8F-84CD-063C1CE3F9D0</gtr:id><gtr:firstName>Ray</gtr:firstName><gtr:surname>Owens</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/053052CA-E492-42AA-8695-9AA1BD24DD6D"><gtr:id>053052CA-E492-42AA-8695-9AA1BD24DD6D</gtr:id><gtr:firstName>Louise Elizabeth</gtr:firstName><gtr:surname>Bird</gtr:surname><gtr:roles><gtr:role><gtr:name>RESEARCHER</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/12A0F313-886D-4BE0-8854-7EE4A715ADD1"><gtr:id>12A0F313-886D-4BE0-8854-7EE4A715ADD1</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Stuart</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MR%2FK018779%2F1"><gtr:id>AAB9A84C-7490-4FC0-994F-C217D97CF1E5</gtr:id><gtr:title>The Oxford Protein Production Facility-UK</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>MR/K018779/1</gtr:grantReference><gtr:abstractText>Proteins are essential components of all living cells. They comprise chains of amino acids coded for by specific DNA sequences and fold into three dimensional structures, that determine their function, for example as biological catalysts. Therefore, understanding protein structure and function is key to exploiting the information generated from sequencing of the human genome and in particular those of many human pathogens. Knowledge of individual proteins has made a major contribution to the development of a number of important drugs, e.g. Zanamivir (influenza neuraminidase inhibitor), Lapatinib (kinase inhibitor), Darunavir (HIV protease inhibitor). However, high throughput DNA sequencing continues to add to the database of known proteins at a rate that far exceeds our capacity to decipher their function. Therefore, accelerating the production of recombinant proteins is key to closing the gap between the acquisition of protein sequences and the determination of their structure and function. In response to this challenge, the Oxford Protein Production Facility will provide infrastructure to underpin the study of proteins on different length and time scales from atomic resolution (x-ray crystallography) to whole cell systems (optical microscopy).</gtr:abstractText><gtr:technicalSummary>The Oxford Protein Production Facility-UK (OPPF-UK) is a National resource for protein science. The overall goal of the OPPF-UK is to provide the UK biological, chemical and biomedical communities with a world-class facility for the production of proteins for structural and functional research. The OPPF-UK has established a high throughput approach to the production of recombinant proteins using three main expression hosts (E. coli, mammalian cells and baculovirus/insect cells) which is provided as a service to the UK scientific community through a peer-review process. Research and development in the OPPF-UK will be focussed on streamlining the cloning, expression and purification of multi-protein complexes and membrane proteins using insect and mammalian cells. Methods will be rolled out as part of the user programme of the OPPF-UK. In parallel, data management systems will be enhanced to provide users with secure on-line access to all project data.</gtr:technicalSummary><gtr:potentialImpactText>Recombinant proteins play a key part in the drug discovery process, for example as components of biochemical screens for new chemical entities (NCEs), antigens for raising therapeutic antibodies and for crystallization to obtain structural information. We are contributing to projects involving the structure-based identification of NCEs, for example inhibitors of a novel metallo-beta-lactamase (NDM-1) which has been implicated in widespread antibiotic resistance of important bacterial pathogens. New knowledge will be added from these studies which may ultimately help in the development of new drugs. The OPPF-UK is developing a number of direct links with the biotech/pharma sector through consultancy and training and as a provider of protein production services. The OPPF-UK is also actively involved in helping to educate the next generation of potential research scientists. We contribute to school visits to the Rutherford Appleton Laboratory through staff giving talks about how proteins are studied in the OPPF-UK and our links with the Diamond Light Source. Finally, the OPPF-UK provides an important opportunity for staff development, since working in the OPPF-UK involves scientists in the management of multiple projects, dealing with deadlines and liaising with external users. This experience helps to develop transferable skills that are highly applicable not only to jobs in research &amp;amp; development but also other professions outside of science.</gtr:potentialImpactText><gtr:fund><gtr:end>2017-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2013-07-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>2585635</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Oswaldo Cruz Foundation (Fiocruz)</gtr:collaboratingOrganisation><gtr:country>Brazil, Federative Republic of</gtr:country><gtr:description>Building research capacity for schistosomiasis drug discovery and development through high-content imaging and structural molecular biology studies</gtr:description><gtr:id>C6610837-A968-4945-B4A9-A1511157A32D</gtr:id><gtr:impact>Technology transfer to Oswaldo Cruz. 
Novel results which will be published in due course.</gtr:impact><gtr:outcomeId>56d84ee505c644.48161503-1</gtr:outcomeId><gtr:partnerContribution>Expertise in drug screening
Identification of potential inhibitors for co-crystallization experiments</gtr:partnerContribution><gtr:piContribution>Training in high throughput cloning and expression of proteins fro drug discovery research.
Protein production and crystallization of Schistosoma proteins selected a potential drug targets.
Delivery of seminar-based workshop at Oswaldo Cruz</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>School visits</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>7FCD2A2F-DD65-458B-BBC4-C7D720D1ABB4</gtr:id><gtr:impact>Practical workshop for year 12 school groups ( approx. 50/visit ) on how recombinant proteins are produced using Green fluorescent protein as the example.</gtr:impact><gtr:outcomeId>56d85877e72c79.36840938</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014,2015,2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science and Society Lecture</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>DFBAE6E8-5450-4825-A461-20AF52A165B7</gtr:id><gtr:impact>Presented at the annual Science and Society lecture - talk sparked questions and discussions afterwords.

Talk could lead to potential collaboration opportunists.</gtr:impact><gtr:outcomeId>545b56947a67c3.98140006</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Science Up Close: Rutherford Appleton Laboratory Open Day</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>D5C37849-46A6-4896-89AA-689E67A6069A</gtr:id><gtr:impact>Hands-on crystallizing a protein for children as part of a stall about proteins and how we study them visited by attendees of the Rutherford Appleton Laboratory Open Day</gtr:impact><gtr:outcomeId>56d856fa131864.88528583</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Schools visit</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>9155AAB9-DF33-45FB-ABC1-4262B8F43704</gtr:id><gtr:impact>Hands-on practical workshops on proteins and protein crystallization</gtr:impact><gtr:outcomeId>58b958070bfb81.35844190</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Youtube video</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>83E1F25E-4B31-4B5F-9E08-D479F239B171</gtr:id><gtr:impact>Video for general audience on protein production and crystallization produced by Backstage Science for the STFC.</gtr:impact><gtr:outcomeId>56d85991805a64.85201549</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=joWNZDBqrlQ</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9733D869-67CA-4107-842B-12A2A74815F1</gtr:id><gtr:title>ENPP1 processes protein ADP-ribosylation in vitro.</gtr:title><gtr:parentPublicationTitle>The FEBS journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b5bfad04815f5e7ad024673280d06f1"><gtr:id>4b5bfad04815f5e7ad024673280d06f1</gtr:id><gtr:otherNames>Palazzo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1742-464X</gtr:issn><gtr:outcomeId>585d399a1d8c92.27086752</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7B5B706E-021C-4EDE-836C-AFAD3B4CF2AE</gtr:id><gtr:title>Substituted 2-(2-aminopyrimidin-4-yl)pyridine-4-carboxylates as potent inhibitors of JumonjiC domain-containing histone demethylases.</gtr:title><gtr:parentPublicationTitle>Future medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/557cab556ce76e401f483f447f85d6ce"><gtr:id>557cab556ce76e401f483f447f85d6ce</gtr:id><gtr:otherNames>Roatsch M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1756-8919</gtr:issn><gtr:outcomeId>585d70eab6b131.20680219</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EEB71F85-B8DE-4871-971A-8A5A33AB70EA</gtr:id><gtr:title>SilE is an intrinsically disordered periplasmic &amp;quot;molecular sponge&amp;quot; involved in bacterial silver resistance.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/80a041996b8220a8255a0b43d0487ac0"><gtr:id>80a041996b8220a8255a0b43d0487ac0</gtr:id><gtr:otherNames>Asiani KR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>585d70e70dc956.32953282</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A93F15F2-B2D2-4589-9D46-0D7D90929ADC</gtr:id><gtr:title>Assay platform for clinically relevant metallo-?-lactamases.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0dfdfe9fc54a5d25ec63c34b1d17a7bb"><gtr:id>0dfdfe9fc54a5d25ec63c34b1d17a7bb</gtr:id><gtr:otherNames>van Berkel SS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>pm_22873_23_23898798</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>17B14EB1-0998-4A44-99BC-CBE7D771E26E</gtr:id><gtr:title>Green fluorescent protein-based expression screening of membrane proteins in Escherichia coli.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b564b6b95e0c7ea6f5ec304bd584a1a2"><gtr:id>b564b6b95e0c7ea6f5ec304bd584a1a2</gtr:id><gtr:otherNames>Bird LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>5675de9bc66e5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6193E331-C313-4D04-957A-4D7CDA5C0936</gtr:id><gtr:title>Chromophore-linked substrate (CLS405): probing metallo-?-lactamase activity and inhibition.</gtr:title><gtr:parentPublicationTitle>ChemMedChem</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/874d6309298a92bbf46070c0982fd4e9"><gtr:id>874d6309298a92bbf46070c0982fd4e9</gtr:id><gtr:otherNames>Makena A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1860-7179</gtr:issn><gtr:outcomeId>pm_22873_23_24166830</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F0CED0E-C26A-4F03-8091-96D502627879</gtr:id><gtr:title>Structural and Kinetic Characterization of Thymidine Kinase from Leishmania major.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/236707122f69f7d0d1e982c368ec9614"><gtr:id>236707122f69f7d0d1e982c368ec9614</gtr:id><gtr:otherNames>Timm J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>5675e48744a23</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A76184F2-9EFF-421A-8BAE-2AF723E24694</gtr:id><gtr:title>Codon optimization and factorial screening for enhanced soluble expression of human ciliary neurotrophic factor in Escherichia coli.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8f27db73a0e40cb548e116a5ee31896f"><gtr:id>8f27db73a0e40cb548e116a5ee31896f</gtr:id><gtr:otherNames>Itkonen JM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>58b95f780a0d70.67913928</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E028AEE6-3C48-4488-AA61-801B48DBC716</gtr:id><gtr:title>Diversity between mammalian tolloid proteinases: Oligomerisation and non-catalytic domains influence activity and specificity.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1ae83c4aee69f80d544ef62bb105ac2e"><gtr:id>1ae83c4aee69f80d544ef62bb105ac2e</gtr:id><gtr:otherNames>Bayley CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b95f77d19471.98390936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>723809CB-2162-4516-BB99-0BF231D0591A</gtr:id><gtr:title>Crystal Structures of the Extracellular Domain from PepT1 and PepT2 Provide Novel Insights into Mammalian Peptide Transport.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8eda91afb7201d6df8f785a4ad17d4d6"><gtr:id>8eda91afb7201d6df8f785a4ad17d4d6</gtr:id><gtr:otherNames>Beale JH</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>56d845f78b92d3.09684597</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D8993CF3-2DE2-43AD-9CD1-004C3E847AF7</gtr:id><gtr:title>A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b7a1e6c1d76e70702a15effb81f63589"><gtr:id>b7a1e6c1d76e70702a15effb81f63589</gtr:id><gtr:otherNames>Liu C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>56d845f70b3819.58350986</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F7E01FC-7C51-4509-B448-3587FDF4CFB7</gtr:id><gtr:title>Transient expression in HEK 293 cells: an alternative to E. coli for the production of secreted and intracellular mammalian proteins.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5083c27c32694a5a97d0d79ec526d5b9"><gtr:id>5083c27c32694a5a97d0d79ec526d5b9</gtr:id><gtr:otherNames>Nettleship JE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5675dd3af12fe</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>960DCF28-1583-4B60-912E-4C54B6ABF355</gtr:id><gtr:title>Expression Screening of Integral Membrane Proteins by Fusion to Fluorescent Reporters.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b564b6b95e0c7ea6f5ec304bd584a1a2"><gtr:id>b564b6b95e0c7ea6f5ec304bd584a1a2</gtr:id><gtr:otherNames>Bird LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>58b95f77a633b9.28243936</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E73480A9-A92D-4570-A0F1-764650FBC612</gtr:id><gtr:title>Functional and structural characterization of a novel putative cysteine protease cell wall-modifying multi-domain enzyme selected from a microbial metagenome.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/405a8aa2dead93ca9eaef46dde417b67"><gtr:id>405a8aa2dead93ca9eaef46dde417b67</gtr:id><gtr:otherNames>Faheem M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>58b95f772e6013.30020430</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F5FD18B-8561-4B6C-A459-429FF07E0606</gtr:id><gtr:title>Adhiron: a stable and versatile peptide display scaffold for molecular recognition applications.</gtr:title><gtr:parentPublicationTitle>Protein engineering, design &amp; selection : PEDS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3968d21e716c138f17c9ffc640a6e897"><gtr:id>3968d21e716c138f17c9ffc640a6e897</gtr:id><gtr:otherNames>Tiede C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1741-0126</gtr:issn><gtr:outcomeId>5458e456578b67.88829526</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2457073B-55F9-4599-8D31-5BA5488AAB5A</gtr:id><gtr:title>Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.</gtr:title><gtr:parentPublicationTitle>Nature medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4596ee70ba87c18360617a95487bcd71"><gtr:id>4596ee70ba87c18360617a95487bcd71</gtr:id><gtr:otherNames>West NR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1078-8956</gtr:issn><gtr:outcomeId>5a35b02a6be8a2.00438846</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A4E9956B-B498-4E93-8DB5-3782CE6E9AAC</gtr:id><gtr:title>Crystal structures of penicillin-binding protein 3 in complexes with azlocillin and cefoperazone in both acylated and deacylated forms.</gtr:title><gtr:parentPublicationTitle>FEBS letters</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ba5128fcb9e215cb4a5503c3d8ebf348"><gtr:id>ba5128fcb9e215cb4a5503c3d8ebf348</gtr:id><gtr:otherNames>Ren J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0014-5793</gtr:issn><gtr:outcomeId>56d845f65718a2.57431388</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>311AE3CC-4D67-481C-AC10-52416D5BB575</gtr:id><gtr:title>Cell cycle regulation and novel structural features of thymidine kinase, an essential enzyme in Trypanosoma brucei.</gtr:title><gtr:parentPublicationTitle>Molecular microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ee42ec17c643b990122ab088ff218271"><gtr:id>ee42ec17c643b990122ab088ff218271</gtr:id><gtr:otherNames>Valente M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0950-382X</gtr:issn><gtr:outcomeId>58b95f77831a97.20129837</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4D7DA3FE-66B6-40E9-A128-C0CBCC4BD5C8</gtr:id><gtr:title>Affimer proteins inhibit immune complex binding to Fc?RIIIa with high specificity through competitive and allosteric modes of action.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40b1b4d714ec05126f83b168ee523b09"><gtr:id>40b1b4d714ec05126f83b168ee523b09</gtr:id><gtr:otherNames>Robinson JI</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>5a6373fe4d8d13.11079895</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>668EC547-7106-45A1-8AAC-B8B58EDE15D3</gtr:id><gtr:title>GFP-based expression screening of membrane proteins in insect cells using the baculovirus system.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a915c02191e0fd14739233ee1478c670"><gtr:id>a915c02191e0fd14739233ee1478c670</gtr:id><gtr:otherNames>Hu NJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>585d592210d828.46258175</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0EF013E6-6DF1-49E5-8BE5-D1A89A764CF5</gtr:id><gtr:title>Comparison of the Structure and Activity of Glycosylated and Aglycosylated Human Carboxylesterase 1.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/932978be8eade4d533f55ef96e314047"><gtr:id>932978be8eade4d533f55ef96e314047</gtr:id><gtr:otherNames>Arena de Souza V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>56d845f693daa0.97458800</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9D6EBE93-8136-42B5-98A8-5F41EB536142</gtr:id><gtr:title>Application of In-Fusion? cloning for the parallel construction of E. coli expression vectors.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b564b6b95e0c7ea6f5ec304bd584a1a2"><gtr:id>b564b6b95e0c7ea6f5ec304bd584a1a2</gtr:id><gtr:otherNames>Bird LE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>pm_540e198e198936c68</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F079C4BC-DD34-4811-BC62-DC97978022F9</gtr:id><gtr:title>High-resolution structures of Lactobacillus salivarius transketolase in the presence and absence of thiamine pyrophosphate.</gtr:title><gtr:parentPublicationTitle>Acta crystallographica. Section F, Structural biology communications</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/361e9f9c22769206761aca802a7c7421"><gtr:id>361e9f9c22769206761aca802a7c7421</gtr:id><gtr:otherNames>Lukacik P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2053-230X</gtr:issn><gtr:outcomeId>56d845f6c7caa0.62051216</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>955FBD3D-D9CE-486A-A8D7-265815029912</gtr:id><gtr:title>Affimer proteins are versatile and renewable affinity reagents.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3968d21e716c138f17c9ffc640a6e897"><gtr:id>3968d21e716c138f17c9ffc640a6e897</gtr:id><gtr:otherNames>Tiede C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>5a8ea07ab13325.82799524</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9F73933F-8E56-49A9-BA00-B1358162DB4B</gtr:id><gtr:title>A streamlined implementation of the glutamine synthetase-based protein expression system.</gtr:title><gtr:parentPublicationTitle>BMC biotechnology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c8564bfa53ae6b4a72f7817544a1510f"><gtr:id>c8564bfa53ae6b4a72f7817544a1510f</gtr:id><gtr:otherNames>Knox R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1472-6750</gtr:issn><gtr:outcomeId>pm_22873_23_24063773</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F3AA2983-395C-45EC-9762-FE943748AB45</gtr:id><gtr:title>The Human Mixed Lineage Leukemia 5 (MLL5), a Sequentially and Structurally Divergent SET Domain-Containing Protein with No Intrinsic Catalytic Activity.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0f5975252baa47f6e63a4cd7e2a0213d"><gtr:id>0f5975252baa47f6e63a4cd7e2a0213d</gtr:id><gtr:otherNames>Mas-Y-Mas S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>58b95f77592d23.18739255</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5F06BDE5-1959-4202-992B-19C8F3E0C34C</gtr:id><gtr:title>Functional and phylogenetic evidence of a bacterial origin for the first enzyme in sphingolipid biosynthesis in a phylum of eukaryotic protozoan parasites.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/820a36e2807571ca73d4f55fbc721a22"><gtr:id>820a36e2807571ca73d4f55fbc721a22</gtr:id><gtr:otherNames>Mina JG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>5a2fd35a2ff178.30916377</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>23D57703-A9BB-49D2-8E69-B499AAF449D8</gtr:id><gtr:title>Click chemistry armed enzyme-linked immunosorbent assay to measure palmitoylation by hedgehog acyltransferase.</gtr:title><gtr:parentPublicationTitle>Analytical biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e00ce7eabc0dd386f4e93314070b4cd1"><gtr:id>e00ce7eabc0dd386f4e93314070b4cd1</gtr:id><gtr:otherNames>Lanyon-Hogg T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0003-2697</gtr:issn><gtr:outcomeId>56d845f75c9c53.43574402</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MR/K018779/1</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>F3822669-BB5A-4BB4-BAE0-DCB9DE36E092</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Generic Health Relevance</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1A41A859-2076-46E6-B80F-CE4E1E8EDC1D</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.5  Resources and infrastructure (underpinning)</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>93C4699B-9E5C-4982-9CCC-EFD5B9712D6E</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.6  Resources and infrastructure (aetiology)</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>